Celmatix Inc.

About Celmatix Inc.

Celmatix Inc. is a preclinical-stage biotech company based in New York City and Cambridge, MA, focused on pioneering a new category of women's health therapeutics termed 'ovarian health.' Their mission is to develop transformative drugs specifically for women to address conditions rooted in ovarian dysfunction, such as endometriosis, premature menopause, and PCOS, enabling women to live longer, healthier lives.

Products & Services

AMHR2 Agonist Program:A drug program focused on ovarian aging to improve ovarian health and function.

Oral FSH Receptor Agonist:A fertility treatment drug aimed at transforming infertility treatments for both men and women.

Immunotherapy for Endometriosis:A novel Jun-N-terminal kinase (JNK) inhibitor targeting pain and inflammation in endometriosis, with potential applications for PCOS and ovarian aging.

Melatonin Receptor Agonist:A collaborative program with Aché Laboratórios to investigate peripherally preferred melatonin receptor agonists for women's health indications, starting with PCOS.

Specialties

Ovarian Health Women's Health Therapeutics Endometriosis Treatment Fertility Treatments Ovarian Aging Polycystic Ovary Syndrome (PCOS)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Award T: - FT: Award	A: 3500000 MR: - FA: 3.5 million FAN: 3500000	D: 2024-10-23 FD: 2024-10-23	1 investors

Award Latest

2024-10-23

$3.5M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Piraye Yurttas Beim

Founder & CEO

S

Stephen Palmer

CSO

A

Adrienne Day

CBO

K

Keith Dewedoff

CFO

C

Craig Bolton

General Counsel

L

Linda C. Giudice

Distinguished Professor, Chair Emerita, and the Robert B. Jaffe MD Endowed Professor in the Reproductive Sciences

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

Celmatix Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised